R21 Planning Grant for the CCTRHIB Program
R21 Planning Grant for the CCTRHIB Program
批准号:
6700423
负责人:
Thomas M Moran
金额:
$33.9万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-01 至 2004-08-31
关键词:
T lymphocyte biomedical facility biomedical registry /referral center bioterrorism /chemical warfare dendritic cells experimental designs immunity literature survey meeting /conference /symposium technology /technique development tissue /cell culture transfection /expression vector vascular endothelium virus genetics virus protein
中文摘要
描述(由申请人提供):本申请是CCTRHIB项目的R21规划资助。在为期一年的资助期内,我们将达致三个目标。首先,我们将组织临床和研究人员组成一个中心,专门研究人类对传染性病原体的免疫反应。我们将强调并鼓励针对可能成为生物恐怖分子的微生物开展工作。该中心的组织将包括创建一个研讨会系列、正在进行的工作系列和一个期刊俱乐部。纽约科学院每年两次的专题讨论会将包括一次专门讨论人类免疫和生物恐怖主义制剂的会议。在这一年中,我们将开发转化中心的基本原理和研究设计。按照目前的设想,该中心将致力于开发与阻断先天免疫或启动特异性免疫的病毒蛋白相关的技术和研究。预期通过这种类型的研究将收集信息,以便开发用作疫苗的突变病毒。此外,病毒基因将被插入到活病毒载体中,并在人体细胞系统中测试其免疫原性和先天免疫刺激活性。为了与该中心目前的基本原理保持一致,人类原代细胞将被用于先天免疫和特异性免疫起始的测定。在R21任职期间,我们将开发从不同目标组织中收集和生长人类上皮细胞的技术。我们还将找到可能的组织来源,以便从不同年龄、性别和种族的患者身上培养细胞。树突状细胞的大规模生长技术也将得到发展。将在这些细胞中测试病毒制剂、突变病毒或含有病毒基因的发育载体,以确定它们对树突状细胞成熟的影响。此外,受感染的DC将被测试它们使用人类T细胞刺激免疫反应的能力。这项工作的目的是建立一个具有共同兴趣和目标的互动研究小组,从而提交U19拨款,创建一个专门研究人类免疫学和微生物的转化中心,这些转化中心有可能被用作生物恐怖主义制剂。
英文摘要
DESCRIPTION (provided by applicant): This application is for an R21 Planning Grant for the CCTRHIB program. During the one-year tenure of this grant, we will accomplish three aims. First we will organize clinical and research investigators into a center dedicated to the study of human immune responses to infectious agents. We will emphasize and encourage the work to be aimed at microbes with the potential as bioterrorist agents. Organization of the center will included the creation of a seminar series, work in progress series and a journal club. A session devoted to human immunity and bioterrorist agents will be included in a twice yearly symposium at the New York Academy of Sciences. During this year we will develop the rationale and research design for the Translational Center. As currently envisioned the center will be devoted to the development of technology and research relating to viral proteins which function to block innate immunity or the initiation of specific immunity. It is expected that through studies of this type information will be gathered that will allow the development of mutant viruses for use as vaccines. Additionally, viral genes will be inserted into live virus vectors and tested for their immunogenicity and innate immune stimulating activity in human cell systems. In keeping with the current rationale of the center, human primary cells will be used in assays of both innate and the initiation of specific immunity. During the tenure of the R21 we will develop techniques for collecting and growth of human epithelial cells from different target tissue. We will also locate possible sources of tissue in order to grow cells from patients of varying age, sex, and ethnicity. Techniques for large-scale growth of dendritic cells will also be developed. The viral agents, mutant viruses or developed vectors containing viral genes will be tested in these cells to determine their effects on the maturation of DCs. Additionally, the infected DC will be tested for their ability to stimulate immune responses using human T cells. This work is aimed to develop an interactive group of investigators with common interests and goals that will lead to the submission of a U19 grant for creation of a Translational Center devoted to the study of Human Immunology and microbes with the potential to be used as bioterrorist agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Center for Investigating Viral Immunity and Antagonism
-
批准号:7924262
-
项目类别:
-
资助金额:$140.0万
-
财政年份:2009
-
负责人:Thomas M Moran
-
依托单位:
Inflammatory Response in Influenza Virus Infection
-
批准号:7905026
-
项目类别:
-
资助金额:$72.07万
-
财政年份:2009
-
负责人:Thomas M Moran
-
依托单位:
Inflammatory Response in Influenza Virus Infection
-
批准号:7679763
-
项目类别:
-
资助金额:$75.47万
-
财政年份:2009
-
负责人:Thomas M Moran
-
依托单位:
Inflammatory Dendritic Cells in Influenza Virus Infection
-
批准号:7498938
-
项目类别:
-
资助金额:$20.23万
-
财政年份:2007
-
负责人:Thomas M Moran
-
依托单位:
Inflammatory Dendritic Cells in Influenza Virus Infection
-
批准号:7391491
-
项目类别:
-
资助金额:$24.86万
-
财政年份:2007
-
负责人:Thomas M Moran
-
依托单位:
Center for Investigating Viral Immunity and Antagonism
-
批准号:6948195
-
项目类别:
-
资助金额:$404.21万
-
财政年份:2004
-
负责人:Thomas M Moran
-
依托单位:
Technological Development Component
-
批准号:6849599
-
项目类别:
-
资助金额:$163.32万
-
财政年份:2004
-
负责人:Thomas M Moran
-
依托单位:
Center for Investigating Viral Immunity and Antagonism
-
批准号:7285664
-
项目类别:
-
资助金额:$396.08万
-
财政年份:2004
-
负责人:Thomas M Moran
-
依托单位:
Center for Investigating Viral Immunity and Antagonism
-
批准号:7492932
-
项目类别:
-
资助金额:$395.9万
-
财政年份:2004
-
负责人:Thomas M Moran
-
依托单位:
Center for Investigating Viral Immunity and Antagonism
-
批准号:7112409
-
项目类别:
-
资助金额:$401.2万
-
财政年份:2004
-
负责人:Thomas M Moran
-
依托单位:
Core--Educational Component
-
批准号:6849607
-
项目类别:
-
资助金额:$15.98万
-
财政年份:2004
-
负责人:Thomas M Moran
-
依托单位:
Center for Investigating Viral Immunity and Antagonism
-
批准号:6845471
-
项目类别:
-
资助金额:$397.19万
-
财政年份:2004
-
负责人:Thomas M Moran
-
依托单位:
VIRUS INDUCED DC MATURATION AND CELLULAR IMMUNITY
-
批准号:6610319
-
项目类别:
-
资助金额:$14.98万
-
财政年份:2002
-
负责人:Thomas M Moran
-
依托单位:
VIRUS INDUCED DC MATURATION AND CELLULAR IMMUNITY
-
批准号:6480395
-
项目类别:
-
资助金额:$14.98万
-
财政年份:2001
-
负责人:Thomas M Moran
-
依托单位:
VIRUS INDUCED DC MATURATION AND CELLULAR IMMUNITY
-
批准号:6331753
-
项目类别:
-
资助金额:$14.98万
-
财政年份:2000
-
负责人:Thomas M Moran
-
依托单位:
CORE--Monoclonal Antibody Facility
-
批准号:6345911
-
项目类别:
-
资助金额:$16.67万
-
财政年份:2000
-
负责人:Thomas M Moran
-
依托单位:
CORE--Monoclonal Antibody Facility
-
批准号:6201086
-
项目类别:
-
资助金额:$16.67万
-
财政年份:1999
-
负责人:Thomas M Moran
-
依托单位:
Th1 and Th2 Responses in Viral Immunity
-
批准号:7385910
-
项目类别:
-
资助金额:$31.53万
-
财政年份:1998
-
负责人:Thomas M Moran
-
依托单位:
Th1 and Th2 Responses in Viral Immunity
-
批准号:7039106
-
项目类别:
-
资助金额:$33.1万
-
财政年份:1998
-
负责人:Thomas M Moran
-
依托单位:
TH1 and TH2 Responses in Viral Immunity
-
批准号:7664222
-
项目类别:
-
资助金额:$38.14万
-
财政年份:1998
-
负责人:Thomas M Moran
-
依托单位:
海外基金